Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.97
-1.15 (-7.61%)
At close: Nov 15, 2024, 4:00 PM
14.05
+0.08 (0.57%)
After-hours: Nov 15, 2024, 7:45 PM EST
Intellia Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$57.25
Upside
+309.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $60 | Buy | Maintains | $70 → $60 | +329.49% | Nov 11, 2024 |
| Barclays | Barclays | Buy Maintains $76 → $55 | Buy | Maintains | $76 → $55 | +293.70% | Nov 8, 2024 |
| Citigroup | Citigroup | Hold Maintains $25 → $19 | Hold | Maintains | $25 → $19 | +36.01% | Oct 25, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $31 → $20 | Hold | Maintains | $31 → $20 | +43.16% | Oct 25, 2024 |
| Baird | Baird | Hold Maintains $24 → $18 | Hold | Maintains | $24 → $18 | +28.85% | Oct 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $94 → $88 | Strong Buy | Maintains | $94 → $88 | +529.92% | Oct 24, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $54 | Buy | Reiterates | $54 | +286.54% | Sep 19, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +193.49% | Sep 17, 2024 |
| Stifel | Stifel | Strong Buy Maintains $80 → $64 | Strong Buy | Maintains | $80 → $64 | +358.12% | Sep 11, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $61 → $55 | Buy | Maintains | $61 → $55 | +293.70% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $54 | Buy | Maintains | $60 → $54 | +286.54% | Aug 9, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $73 | Strong Buy | Maintains | $73 | +422.55% | Jun 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +365.28% | Jun 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 | Strong Buy | Maintains | $120 | +758.98% | Jun 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +365.28% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +365.28% | Jun 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.